Misplaced Pages

Co-amilofruse (BAN) is a nonproprietary name used to denote a combination of amiloride and furosemide, which are both diuretics. Co-amilofruse is a treatment for fluid retention (oedema), either in the legs (peripheral edema) or on the lungs (pulmonary oedema). Furosemide is a loop diuretic and is more effective than amiloride, but has a tendency to cause low potassium levels (hypokalaemia); the potassium-sparing effects of amiloride may balance this.

Formulation

Two strengths of co-amilofruse are available:

• 2.5 mg amiloride with 20 mg furosemide, BAN of Co-amilofruse 2.5/20 (brand name Frumil LS)
• 5 mg amiloride with 40 mg furosemide, BAN of Co-amilofruse 5/4-0 (brand name Frumil)

References

1. Hitchings A, Lonsdale D, Burrage D, Baker E (2014). Top 100 drugs : clinical pharmacology and practical prescribing. Edinburgh: Elsevier Health Sciences. p. 113. ISBN 978-0-7020-5515-7.

• British National Formulary 2004

This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Loop diuretics
• Potassium-sparing diuretics
• Combination drugs
• Cardiovascular system drug stubs